Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Challenger ( (AU:CGF) ) just unveiled an announcement.
Challenger Limited has announced that it has ceased to be a substantial holder in Monash IVF Group Limited. This change reflects a shift in Challenger’s investment strategy, potentially impacting its portfolio and market positioning. The announcement may have implications for stakeholders, including adjustments in voting rights and investment focus.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
More about Challenger
Challenger Limited operates in the financial services industry, offering a range of investment and retirement solutions. The company focuses on providing life insurance, investment management, and retirement income products, catering to individuals and institutional clients.
Average Trading Volume: 2,475,402
Technical Sentiment Signal: Buy
Current Market Cap: A$5.43B
See more insights into CGF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue